Nuclear Medicine therapy Shows Long-Term Effectiveness for Malignant Neuroendocrine Tumors. (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Nuclear Medicine therapy Shows Long-Term Effectiveness for Malignant Neuroendocrine Tumors.

Caption

Graph showing that only 18% of patients initially treated with 90Y-therapy were alive after 12 years, whereas nearly 48% of patients in 177Lu group were alive.

Credit

M Gabriel and IJ Virgolini, et al., Department of Nuclear Medicine, Medical University of Innsbruck, Austria.

Usage Restrictions

Please give appropriate credit and indicate if changes were made.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.